Alzheimer's Agent Fails; Antiseizure Drug Use Rises; Stress and Post-COVID Outcomes
News and commentary from the world of neurology and neuroscience
Stay updated with breaking news from Brain Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
News and commentary from the world of neurology and neuroscience
Contrary to earlier findings, new research shows there is no impact of erectile dysfunction on Alzheimer's or dementia risk.
Phosphodiesterase-5 (PDE5) inhibitors seem not to be associated with a reduced risk for Alzheimer disease and related dementia.
Phosphodiesterase-5 (PDE5) inhibitors seem not to be associated with a reduced risk for Alzheimer disease and related dementia.
WEDNESDAY, Oct. 19, 2022 (HealthDay News) -- Phosphodiesterase-5 (PDE5) inhibitors seem not to be associated with a reduced risk for Alzheimer disease and related dementia, according to a study published online Oct. 4 in Brain Communications. Rishi J. Desai, Ph.D., from Brigham and Women's Hospital and Harvard Medical School in Boston, and colleagues compared the